PMID: 3758945Sep 1, 1986Paper

Prognostic value of the aminopyrine breath test in cirrhotic patients

Hepatology : Official Journal of the American Association for the Study of Liver Diseases
J P VilleneuveD Marleau

Abstract

The aminopyrine breath test has been proposed as a quantitative test of hepatic function, but its long-term prognostic value in patients with cirrhosis has not been determined. The aim of this study was to examine the usefulness of the aminopyrine breath test in assessing prognosis and to compare it with traditional methods of evaluating liver function. One-hundred eighty-seven patients with histologically confirmed cirrhosis were studied prospectively. An aminopyrine breath test was obtained at the time of inclusion in the study and results were expressed as per cent of the dose excreted in 2 hr. At inclusion, the severity of liver disease was also assessed according to the Pugh modification of the Child-Turcotte classification based on ascites, neurological status, serum albumin, serum bilirubin and prothrombin time. Mean follow-up was 844 days. During that period, 59 of 187 patients died of their liver disease. Two-year survival decreased with increasing Child-Turcotte classification score: survival was 98% in Child Class A patients (n = 62), 66% in Child Class B (n = 76) and 36% in Child Class C (n = 49) (chi 2 = 65.6, p less than 0.001). Two-year survival also decreased significantly with increasing degree of aminopyrine b...Continue Reading

References

Oct 1, 1976·Clinical Pharmacology and Therapeutics·J BircherR Preisig
Sep 1, 1985·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·E ChristensenN Tygstrup
Mar 1, 1985·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·D C NelsonS Schenker
Aug 1, 1973·The British Journal of Surgery·R N PughR Williams
Apr 1, 1974·European Journal of Clinical Investigation·P B AndreasenN Tygstrup
Jan 1, 1984·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·E RennerR Preisig
Jan 1, 1984·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·K J BreenM L Mashford
Sep 1, 1984·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·K A BlackT R Tephly
May 1, 1984·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·E ChristensenN Tygstrup
Jan 1, 1982·Digestive Diseases and Sciences·S PauwelsC Beckers
Jul 1, 1982·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·A F Hofmann
Jan 1, 1982·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·R A Branch
May 1, 1982·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·P S MonroeD Schoeller
Feb 2, 1980·British Medical Journal·J B SaundersK O Lewis

❮ Previous
Next ❯

Citations

Jan 4, 1989·Klinische Wochenschrift·A HolstegeW Gerok
Apr 1, 1994·European Journal of Drug Metabolism and Pharmacokinetics·J GuittonJ L Brazier
Sep 3, 2008·European Journal of Clinical Pharmacology·Roger K Verbeeck
Dec 1, 1995·Baillière's Clinical Gastroenterology·E L Renner
Sep 1, 1996·Journal of Hepatology·R JalanH J Hodgson
Jan 20, 1999·Alimentary Pharmacology & Therapeutics·L FabrisL Okolicsanyi
Nov 28, 2002·Alimentary Pharmacology & Therapeutics·A ArmuzziA Gasbarrini
Jun 1, 1992·International Journal of Dermatology·A C VerschuurR A Chamuleau
Jul 1, 1990·Journal of Gastroenterology and Hepatology·N Tygstrup
May 5, 1999·Liver·M BernardiP Gentilini
Aug 1, 1990·Pharmacology & Toxicology·S Loft, H E Poulsen
Dec 1, 1988·The Journal of Clinical Investigation·J ReichenA Zimmermann
Sep 1, 1990·Journal of Clinical Chemistry and Clinical Biochemistry. Zeitschrift Für Klinische Chemie Und Klinische Biochemie·P AmodioA Gatta
Oct 1, 1988·Digestive Diseases and Sciences·C SacchettiM Ponz de Leon
Jan 1, 1991·La Ricerca in Clinica E in Laboratorio·G Molino
Dec 1, 1987·Scandinavian Journal of Gastroenterology·S LoftM Døssing
Oct 28, 2003·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Gordon Jung-Hyuk ParkMeng Chong Ngu
Jan 1, 1989·Journal of Clinical Epidemiology·C Infante-RivardS Esnaola
Aug 1, 1989·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·S J Williams, G C Farrell
Jul 1, 1989·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·E Christensen
Jul 1, 1987·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·C Infante-RivardJ P Villeneuve
Mar 1, 1988·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·C GluudG Nielsen
Dec 17, 2011·Journal of Hepatology·Alba RoccoGerardo Nardone
Jun 23, 2001·The American Journal of Gastroenterology·M DelhayeP Galand
Oct 1, 1996·Journal of Clinical Pharmacology·A BerndtM Weiss
Sep 1, 1991·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·J ReichenJ Cotting

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.